• Greenlee and Goins Join Faculty
• Braun & Scheetz
• Scott Honored
• Faculty News
• Visiting Researchers
• House Staff News
  • Graduates
  • New Residents
  • New Fellows
• Update from the Chair

• Bioinformatics Grant
• Carver Lab
• Iowa Lions Eye Bank, Ames Office
• ConfoScan Grant
• Laser Vision Center
• Alumni
• Opportunities for Giving
• Join us at the 2003 AAO Meeting
• Calendar

Greenlee and Goins Join Faculty

Emily C. Greenlee, MD, is a new Associate. She is involved in patient care and teaching in both the Glaucoma Clinic and the Comprehensive Ophthalmology Clinic.

Dr. Greenlee did both her residency and glaucoma fellowship at the University of Iowa. She has a Bachelor of Business Administration from the University of Notre Dame. She was in the Post-Baccalaureate Pre-Health Professions Program at Loyola University of Chicago, earned her M.D. from Indiana University School of Medicine, and did her internship at the University of Iowa Hospitals and Clinics. Her husband, Jeremy, is the Chief Resident in Neurosurgery at UIHC this year.

Kenneth Goins, MD, joined the faculty of the Cornea and External Disease Service in late July. He comes to the University of Iowa from the University of Chicago. Dr. Goins has a BA degree in Organismal and Systems Biology from the University of Tennessee at Knoxville and earned his M.D. from the University of Kentucky in Lexington, where he also did his internship and ophthalmology residency. He was a fellow in cornea and external disease at Duke University Eye Center at Durham, North Carolina. While at Chicago, he helped develop the cataract surgery program, becoming the primary teacher of phacoemulsification. He made a large contribution in markedly lowering the cataract complication rate.

Besides participating in patient care and teaching in the Cornea and External Disease Service, his goals at the University of Iowa are to work on research projects including deep lamellar endothelial transplantation (DLEK) for posterior corneal disorders (i.e. Fuchs' dystrophy, posterior polymorphous dystrophy, and iridocorneal endothelial syndrome) and the use of the Alpha-Cor artificial cornea, a new type of keratoprosthesis made for patients who are at high risk for corneal transplant rejection. He plans to continue his previous work in the use of Morcher endocapsular tension rings for patients with lens subluxation and zonular weakness, use of the Morcher black iris diaphragm aniridia implant for patients with partial or complete iris defects, and the use of Intacs for keratoconus. He also plans to continue his investigations into the ocular applications of Minoxidil in the prevention of posterior capsular opacification and to reduce corneal haze after excimer laser surface ablations.